533
Views
59
CrossRef citations to date
0
Altmetric
Oesophagus

Epidemiology of symptom-defined gastroesophageal reflux disease and reflux esophagitis: The systematic investigation of gastrointestinal diseases in China (SILC)

, , , , , , , , , , , , , , & show all
Pages 133-141 | Received 27 Apr 2010, Accepted 02 Sep 2010, Published online: 19 Oct 2010

References

  • Armstrong D. Systematic review: persistence and severity in gastroesophageal reflux disease. Aliment Pharmacol Ther 2008;28:841–53.
  • Vakil N, Veldhuyzen van Zanten S, Kahrilas P, Dent J, Jones R. The Montreal definition and classification of gastro-esophageal reflux disease (GERD) – a global evidence-based consensus. Am J Gastroenterol 2006;101:1900–20.
  • Dent J, El-Serag HB, Wallander MA, Johansson S. Epidemiology of gastro-oesophageal reflux disease: a systematic review. Gut 2005;54:710–17.
  • El-Serag HB. Time trends of gastroesophageal reflux disease: a systematic review. Clin Gastroenterol Hepatol 2007;5:17–26.
  • Dent J. Microscopic esophageal mucosal injury in nonerosive reflux disease. Clin Gastroenterol Hepatol 2007;5:4–16.
  • Zagari RM, Fuccio L, Wallander MA, Johansson S, Fiocca R, Casanova S, Gastro-oesophageal reflux symptoms, oesophagitis and Barrett's oesophagus in the general population: Loiano-Monghidoro study. Gut 2008;57:1354–9.
  • Ronkainen J, Aro P, Storskrubb T, Johansson SE, Lind T, Bolling-Sternevald E, High prevalence of gastroesophageal reflux symptoms and esophagitis with or without symptoms in the general adult Swedish population: a Kalixanda study report. Scand J Gastroenterol 2005;40:275–85.
  • Ronkainen J, Aro P, Storskrubb T, Johansson SE, Lind T, Bolling-Sternevald E, Prevalence of Barrett's esophagus in the general population: an endoscopic study. Gastroenterology 2005;129:1825–31.
  • Lagergren J, Bergstrom R, Lindgren A, Nyren O. Symptomatic gastroesophageal reflux as a risk factor for esophageal adenocarcinoma. N Engl J Med 1999;340:825–31.
  • Wong BCY, Kinoshita Y. Systematic review on epidemiology of gastroesophageal reflux disease in Asia. Clin Gastroenterol Hepatol 2006;4:398–407.
  • Cao Y, Yan X, Ma X, Wang R, Fu Z, Johansson S, Validation of a survey methodology for gastroesophageal reflux disease in China. BMC Gastroenterol 2008;8:37.
  • Yan X, Wang R, Zhao Y, Ma X, Fang J, Yan H, Systematic investigation of gastrointestinal diseases in China (SILC): validation of survey methodology. BMC Gastroenterol 2009;9:86.
  • Dent J, Vakil N, Jones R, Reimitz P, Schöning U, Halling K, Validation of the reflux disease questionnaire for the diagnosis of gastroesophageal reflux disease in primary care. Gut 2007;56(Suppl 3):A75.
  • Veldhuyzen van Zanten S, Flook N, Talley NJ, Vakil N, Lauritsen K, Bolling-Sternevald E, One-week acid suppression trial in uninvestigated dyspepsia patients with epigastric pain or burning to predict response to 8 weeks' treatment with esomeprazole: a randomized, placebo-controlled study. Aliment Pharmacol Ther 2007;26:665–72.
  • Johnsson F, Hatlebakk J, Klintenberg AC, Román J. The symptom relieving effect of esomeprazole 40 mg daily in patients with heartburn. Gastroenterology 2001;120(Suppl):A437.
  • Lundell LR, Dent J, Bennett JR, Blum AL, Armstrong D, Galmiche JP, Endoscopic assessment of oesophagitis: clinical and functional correlates and further validation of the Los Angeles classification. Gut 1999;45:172–80.
  • Sharma P, Dent J, Armstrong D, Bergman JJ, Gossner L, Hoshihara Y, The development and validation of an endoscopic grading system for Barrett's esophagus: the Prague C & M criteria. Gastroenterology 2006;131:1392–9.
  • Aro P, Ronkainen J, Storskrubb T, Bolling-Sternevald E, Carlsson R, Johansson SE. Valid symptom reporting at upper endoscopy in a random sample of the Swedish adult general population: the Kalixanda study. Scand J Gastroenterol 2004;39:1280–8.
  • Amano K, Adachi K, Katsube T, Watanabe M, Kinoshita Y. Role of hiatus hernia and gastric mucosal atrophy in the development of reflux esophagitis in the elderly. J Gastroenterol Hepatol 2001;16:132–6.
  • Mishima I, Adachi K, Arima N, Amano K, Takashima T, Moritani M, Prevalence of endoscopically negative and positive gastroesophageal reflux disease in the Japanese. Scand J Gastroenterol 2005;40:1005–9.
  • Kim N, Lee SW, Cho SI, Park CG, Yang CH, Kim HS, The prevalence and risk factors of erosive oesophagitis and non-erosive reflux disease: a nationwide multi-centre prospective study in Korea. Aliment Pharmacol Ther 2008;27(2):173–85.
  • Lee SJ, Song CW, Jeen YT, Chun HJ, Lee HS, Um SH, Prevalence of endoscopic reflux esophagitis among Koreans. J Gastroenterol Hepatol 2001;16:373–6.
  • Chang CS, Poon SK, Lien HC, Chen GH. The incidence of reflux esophagitis among the Chinese. Am J Gastroenterol 1997;92:668–71.
  • Tseng PH, Lee YC, Chiu HM, Huang SP, Liao WC, Chen CC, Prevalence and clinical characteristics of Barrett's esophagus in a Chinese general population. J Clin Gastroenterol 2008;42:1074–9.
  • Kim JH, Rhee P-L, Lee JH, Lee H, Choi YS, Son HJ, Prevalence and risk factors of Barrett's esophagus in Korea. J Gastroenterol Hepatol 2007;22:908–12.
  • Asling B, Jirholt J, Hammond P, Knutsson M, Walentinsson A, Davidson G, Collagen type III alpha I is a gastro-oesophageal reflux disease susceptibility gene and a male risk factor for hiatus hernia. Gut 2009;58:1063–9.
  • Du J, Liu J, Zhang H, Yu CH, Li YM. Risk factors for gastroesophageal reflux disease, reflux esophagitis and non-erosive reflux disease among Chinese patients undergoing upper gastrointestinal endoscopic examination. World J Gastroenterol 2007;13:6009–15.
  • Haruma K, Hamada H, Mihara M, Kamada T, Yoshihara M, Sumii K, Negative association between Helicobacter pylori infection and reflux esophagitis in older patients: case–control study in Japan. Helicobacter 2000;5:24–9.
  • Labenz J, Blum AL, Bayerdörffer E, Meining A, Stolte M, Börsch G. Curing Helicobacter pylori infection in patients with duodenal ulcer may provoke reflux esophagitis. Gastroenterology 1997;112:1442–7.
  • Raghunath A, Hungin AP, Wooff D, Childs S. Prevalence of Helicobacter pylori in patients with gastro-oesophageal reflux disease: systematic review. BMJ 2003;326:737.
  • Yagi S, Okada H, Takenaka R, Miyoshi M, Suzuki S, Toyokawa T, Influence of Helicobacter pylori eradication on reflux esophagitis in Japanese patients. Dis Esophagus 2009;22:361–7.
  • Ho KY, Chan YH, Kang JY. Increasing trend of reflux esophagitis and decreasing trend of Helicobacter pylori infection in patients from a multiethnic Asian country. Am J Gastroenterol 2005;100:1923–8.
  • Blaser MJ. Hypothesis: the changing relationships of Helicobacter pylori and humans: implications for health and disease. J Infect Dis 1999;179:1523–30.
  • Vaezi MF, Singh S, Richter JE. Role of acid and duodenogastric reflux in esophageal mucosal injury: a review of animal and human studies. Gastroenterology 1995;108:1897–907.
  • World Health Organization. Appropriate body-mass index for Asian populations and its implications for policy and intervention strategies. Lancet 2004;363:157–63.
  • China statistical yearbook: China Statistical Press. 2008. Available online at: http://www.stats.gov.cn/tjsj/ndsj/2008/indexeh.htm (accessed 15 July 2009).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.